David W Gryska - Net Worth and Insider Trading
David W Gryska Net Worth
The estimated net worth of David W Gryska is at least $10 Million dollars as of 2024-12-29. David W Gryska is the Director of Seagen Inc and owns about 40,253 shares of Seagen Inc (SGEN) stock worth over $9 Million. David W Gryska is the Executive Vice President, CFO of Incyte Corp and owns about 10,970 shares of Incyte Corp (INCY) stock worth over $759,453. David W Gryska is also the CFO of Celgene Corp and owns about 3,228 shares of Celgene Corp (CELG) stock worth over $349,399. Besides these, David W Gryska also holds Mind Medicine Inc (MNMD) , PDL BioPharma Inc (PDLI) . Details can be seen in David W Gryska's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David W Gryska has not made any transactions after 2024-12-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David W Gryska
David W Gryska Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David W Gryska owns 9 companies in total, including GW Pharmaceuticals PLC (GWPH) , PDL BioPharma Inc (PDLI) , and Aerie Pharmaceuticals Inc (AERI) among others .
Click here to see the complete history of David W Gryska’s form 4 insider trades.
Insider Ownership Summary of David W Gryska
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GWPH | GW Pharmaceuticals PLC | 2020-09-14 | director |
PDLI | PDL BioPharma Inc | 2020-12-30 | director |
AERI | Aerie Pharmaceuticals Inc | 2013-10-25 | director |
2022-11-11 | director | ||
2018-02-21 | Executive Vice President & CFO | ||
2014-02-06 | director | ||
2012-05-11 | director & Chief Operating Officer | ||
2023-01-10 | director | ||
2024-12-05 | director |
David W Gryska Latest Holdings Summary
David W Gryska currently owns a total of 5 stocks. Among these stocks, David W Gryska owns 40,253 shares of Seagen Inc (SGEN) as of November 11, 2022, with a value of $9 Million and a weighting of 88.06%. David W Gryska owns 10,970 shares of Incyte Corp (INCY) as of February 21, 2018, with a value of $759,453 and a weighting of 7.26%. David W Gryska also owns 3,228 shares of Celgene Corp (CELG) as of May 4, 2010, with a value of $349,399 and a weighting of 3.34%. The other 2 stocks Mind Medicine Inc (MNMD) , PDL BioPharma Inc (PDLI) have a combined weighting of 1.33% among all his current holdings.
Latest Holdings of David W Gryska
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGEN | Seagen Inc | 2022-11-11 | 40,253 | 228.74 | 9,207,471 |
INCY | Incyte Corp | 2018-02-21 | 10,970 | 69.23 | 759,453 |
CELG | Celgene Corp | 2010-05-04 | 3,228 | 108.24 | 349,399 |
MNMD | Mind Medicine Inc | 2024-12-05 | 19,851 | 6.84 | 135,781 |
PDLI | PDL BioPharma Inc | 2020-12-30 | 1,387 | 2.47 | 3,426 |
Holding Weightings of David W Gryska
David W Gryska Form 4 Trading Tracker
According to the SEC Form 4 filings, David W Gryska has made a total of 6 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Seagen Inc is the sale of 7,500 shares on November 11, 2022, which brought David W Gryska around $968,250.
According to the SEC Form 4 filings, David W Gryska has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the sale of 1,952 shares on February 21, 2018, which brought David W Gryska around $167,013.
According to the SEC Form 4 filings, David W Gryska has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 76,186 shares on May 4, 2010, which brought David W Gryska around $2 Million.
More details on David W Gryska's insider transactions can be found in the Insider Trading History of David W Gryska table.Insider Trading History of David W Gryska
- 1
David W Gryska Trading Performance
GuruFocus tracks the stock performance after each of David W Gryska's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David W Gryska is 25.58%. GuruFocus also compares David W Gryska's trading performance to market benchmark return within the same time period. The performance of stocks bought by David W Gryska within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David W Gryska's insider trading performs compared to the benchmark.
Performance of David W Gryska
David W Gryska Ownership Network
David W Gryska Owned Company Details
What does GW Pharmaceuticals PLC do?
Who are the key executives at GW Pharmaceuticals PLC?
David W Gryska is the director of GW Pharmaceuticals PLC. Other key executives at GW Pharmaceuticals PLC include Chief Legal Officer Douglas B. Snyder , Chief Medical Officer Volker Knappertz , and Secretary Adam D. George .
GW Pharmaceuticals PLC (GWPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of GW Pharmaceuticals PLC (GWPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GW Pharmaceuticals PLC (GWPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
GW Pharmaceuticals PLC (GWPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
GW Pharmaceuticals PLC Insider Transactions
David W Gryska Mailing Address
Above is the net worth, insider trading, and ownership report for David W Gryska. You might contact David W Gryska via mailing address: 749 N Mary Ave, Sunnyvale Ca 94085.